Diet-induced metabolic hamster model of nonalcoholic fatty liver disease by Bhathena, Jasmine et al.
© 2011 Bhathena et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 195–203
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
195
OriginAL reSeArch
open access to scientific and medical research
Open Access Full Text Article
DOI: 10.2147/DMSO.S18435
Diet-induced metabolic hamster model  
of nonalcoholic fatty liver disease
Jasmine Bhathena
Arun Kulamarva
christopher Martoni
Aleksandra Malgorzata 
Urbanska
Meenakshi Malhotra
Arghya Paul
Satya Prakash
Biomedical Technology and cell 
Therapy research Laboratory, 
Department of Biomedical 
engineering, Artificial cells and 
Organs research centre, Faculty  
of Medicine, Mcgill University, 
Montreal, Québec, canada
correspondence: Satya Prakash 
3775 University Street, Montreal, 
Québec h3A 2B4, canada 
Tel +1 514 398 3676 
Fax +1 514 398 7461 
email satya.prakash@mcgill.ca
Background: Obesity, hypercholesterolemia, elevated triglycerides, and type 2 diabetes are 
major risk factors for metabolic syndrome. Hamsters, unlike rats or mice, respond well to diet-
induced obesity, increase body mass and adiposity on group housing, and increase food intake 
due to social confrontation-induced stress. They have a cardiovascular and hepatic system similar 
to that of humans, and can thus be a useful model for human pathophysiology.
Methods: Experiments were planned to develop a diet-induced Bio F1B Golden Syrian 
  hamster model of dyslipidemia and associated nonalcoholic fatty liver disease in the metabolic 
syndrome. Hamsters were fed a normal control diet, a high-fat/high-cholesterol diet, a high-
fat/high-cholesterol/methionine-deficient/choline-devoid diet, and a high-fat/high-cholesterol/
choline-deficient diet. Serum total cholesterol, high-density lipoprotein cholesterol, low-density 
lipoprotein cholesterol, triglycerides, glucose, atherogenic index, and body weight were quanti-
fied biweekly. Fat deposition in the liver was observed and assessed following lipid staining 
with hematoxylin and eosin and with oil red O.
Results: In this study, we established a diet-induced Bio F1B Golden Syrian hamster model 
for studying dyslipidemia and associated nonalcoholic fatty liver disease in the metabolic syn-
drome. Hyperlipidemia and elevated serum glucose concentrations were induced using this diet. 
  Atherogenic index was elevated, increasing the risk for a cardiovascular event. Histological analysis 
of liver specimens at the end of four weeks showed increased fat deposition in the liver of animals 
fed with a high-fat/high cholesterol diet, as compared to animals fed with the control diet.
Conclusion: Our study established that hamsters fed with a high-fat/high-cholesterol diet 
developed fatty liver and mild diabetes. Bio F1B hamsters fed with a high-fat/high-cholesterol 
diet may thus be a good animal model for research on the treatment of diet-induced metabolic 
syndrome complicated by nonalcoholic fatty liver disease.
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Introduction
Obesity is exponentially increasing, and its pervasiveness is at epidemic levels in the 
world. Obesity may be the cause of or a precursor to other diseases, such as insulin 
resistance and dyslipidemia (hypertriglyceridemia and reduced high-density lipopro-
tein [HDL] cholesterol). The term “metabolic syndrome” was coined to describe the 
concurrent occurrence of these diseases. Individuals with metabolic syndrome are at 
amplified risk for type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver 
disease.1–3 The liver is a target organ in metabolic syndrome, in which it manifests 
itself as nonalcoholic fatty liver disease, spanning the spectrum of hepatosteatosis to 
hepatocellular carcinoma through steatohepatitis and cirrhosis. Because metabolic Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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syndrome and nonalcoholic fatty liver disease affect the 
same insulin-resistant patients, it stands to reason that there 
would be a similarity between the metabolic syndrome and 
nonalcoholic fatty liver disease in terms of prevalence, 
pathogenesis, clinical features, and outcome.4 The costs of 
treating metabolic syndrome and its associated disorders 
are growing, and the research community is seeking animal 
models that mimic the human phenotype so that potential 
therapies can be tested.
Data from various animal models have provided the con-
ceptual framework for much of the clinical investigations, 
and permit study of the pathophysiology and fundamental 
biological mechanisms of disease. Continued studies in 
animals provide further clarification of the pathogenesis 
of metabolic disorders and may therefore be very useful to 
improve diagnosis and treatment of metabolic syndrome.5–7 
However, the study of the pathophysiologic process of meta-
bolic syndrome and nonalcoholic fatty liver disease is limited 
by the lack of appropriate animal models that can depict 
the combined features of nonalcoholic fatty liver disease 
and the cluster of metabolic abnormalities associated with 
metabolic syndrome.
Obesity is strongly associated with hepatosteatosis 
in humans.8 Nonetheless, it remains unclear whether the 
intake of excessive amounts of food by itself causes fatty 
liver. Because of the pivotal role that diet plays in causing 
metabolic syndrome in humans, most metabolic disease 
animal models use diet as a way to precipitate this   syndrome. 
  Uncertainty abounds as to whether or not diets that are 
augmented with certain types of food are more likely to 
cause obesity and/or fatty liver than other types of diets. 
It is difficult to control for all of the complex genetic and 
environmental factors that control energy homeostasis in 
humans. Therefore, studies that manipulate dietary composi-
tion of food and its consumption in animal models may well 
provide vital insights into the role of diet in the pathogenesis 
of obesity-related hepatic steatosis.
In order to gain a greater understanding of human obe-
sity, rodents are the commonly used models. Generally, 
high-fat diets, high sucrose/fructose diets, diets high in 
saturated fats and restricted in certain essential nutrients, 
like choline and methionine, have been shown to cause 
obesity and fatty livers in a number of different strains and 
species of rodents.9 High-fat/high-cholesterol Western diets 
induce extreme hypercholesterolemia and also lead to con-
comitant features of the metabolic syndrome, such as weight 
gain, decreased HDL levels, obesity,   hypertriglyceridemia, 
hyperinsulinemia, and insulin resistance.10–12 In addition, 
these diets generate pathologies independent of atheroscle-
rosis, such as changes in fur and skin integrity, changes in 
plasma lipids, and hepatic steatosis.13 This suggests that 
“overnutrition” might play a role in the genesis of obesity-
related fatty liver disease and other risk factors associated 
with metabolic syndrome.14 Unfortunately, it is relatively 
difficult to induce obesity in normal rats and mice.15 Not 
all high-fat diets are the same, because both the level and 
source of fat may differ between diets. Most rodents tend 
to become obese on high-fat diets, but there can be vari-
able responses in insulin resistance, triglycerides, and other 
parameters, depending on the strain and gender, and source 
of dietary fat.14 Normal mice and rats are not ideal models 
in which to raise the levels of circulating total cholesterol 
and low-density lipoprotein [LDL] cholesterol, thereby 
increasing the risk of cardiovascular disease. These mod-
els typically have very low levels of total cholesterol and 
LDL cholesterol, but high levels of HDL cholesterol.14–16 
This is in contrast to humans, in whom the reverse is true. 
Moreover, like human populations, rodent populations dif-
fer in their susceptibility to diet-induced obesity and fatty 
liver, suggesting that subtle strain, age, or gender-related 
variations in genetic factors that regulate intermediary 
metabolism probably influence the response to various 
diets. For example, elevated triglycerides are associated 
with an increase in oxidative stress, and special diets are 
needed to mimic lipid profiles similar to those of humans. 
Therefore, it is clear that there is a necessity to develop an 
animal model of metabolic syndrome expressing fatty liver 
and other cardiovascular risk factors. To achieve this goal, 
we used Golden Syrian hamsters, because they have been 
observed to respond consistently to dietary modulation of 
cholesterol, and have shown a close similarity to the human 
lipoprotein profile in comparison with other animals of 
similar size, eg, rats and mice.17
Materials and methods
Animals
Male Bio F1B Golden Syrian hamsters (Mesocricetus 
  auratus, 8 weeks old, approximately 90 g) were obtained from 
  Biobreeders Inc (Watertown, MA) and housed two per cage in a 
room with controlled temperature (22–24°C), humidity and an 
inverse alternating light and dark cycle (12:12-hour light:dark 
cycle, lights on at 7 pm). All experimental protocols complied 
with the Animal Care Committee of McGill University and 
Canadian Council on Animal Care guidelines.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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experimental protocol and diets
After arrival, animals were allowed free access to a basal 
diet of commercial rodent ration (LabDiet® rodent labora-
tory chow 5001, Purina Laboratories, St Louis, MO) and 
water for two weeks to allow adaptation to the environment. 
Baseline values of serum total cholesterol were measured 
at the end of two weeks in hamsters that were deprived of 
food overnight. Further, these basal serum total cholesterol 
values were used to assign animals into four groups using 
a randomized block design. The control group continued 
to be fed the reference diet 5001. Each of the other groups 
(n = 8) was from then onwards fed a grain-based, hyper-
cholesterolemic chow diet (Modified LabDiet laboratory 
rodent diets with added cholesterol and 6% coconut oil 
as saturated fat, Purina Laboratories, see Table 1), with 
free access to water for five weeks. Diet consumption and 
body weight were measured every 10 days. Food efficiency 
ratio was computed as g body weight gain/g feed intake. 
Blood samples were collected once every 14 days from 
food-deprived hamsters (14 hours) that has been mildly 
sedated using 3 µL of 5 mg/mL acepromazine. Briefly, after 
immobilizing the hamster, approximately 150 µL of blood 
was collected from the lateral saphenous vein which runs 
dorsally and then laterally over the tarsal joint with a sterile 
23 gauge/25 mm needle, into Microtainer® serum separator 
tubes from Becton Dickinson (Franklin Lakes, NJ). At the 
end of the experimental period (five weeks), the hamsters 
were euthanized by carbon dioxide asphyxiation and blood 
was withdrawn by cardiac puncture using a 22 gauge/25 mm 
needle and a 5 mL syringe. Cardiac blood was transferred 
into serum separator tubes and allowed to clot prior to 
placement on ice.
Serum cholesterol and triglyceride 
measurements
Blood from hamsters that had been food deprived for 14 hours 
was collected under mild sedation into serum separator 
tubes. The blood was allowed to clot at 23°C for 30 minutes 
and subsequently placed at 4°C until   centrifugation. Serum 
was separated by low-speed centrifugation at 2000 g for 
20     minutes at 4°C temperature. Serum was frozen at −85°C 
until analysis for serum total cholesterol, HDL cholesterol, 
LDL cholesterol, triglycerides, and glucose. Serum total 
lipids and glucose were assayed by conventional enzymatic 
methods on a Hitachi 911 automated analyzer from Roche 
Diagnostics (Laval, QC, Canada). Total cholesterol, HDL 
cholesterol, triglycerides, and glucose were measured on the 
Hitachi 911 automated analyzer using reagent kits supplied 
by Roche Diagnostics. The precision performance of these 
assays was within the manufacturer’s specifications. LDL 
Table 1 Profile of the normal and hypercholesterolemic test diets
LabDiet® reference 
rodent laboratory chow
Modified LabDiet laboratory rodent test diet
Nutritional profile 5001 5A4c 5D4F 5D4e
Protein, % 23.9 25 15.1 22.5
Fat (ether extract), % 5 10.3 10 10.2
Total saturated fatty acids, % 1.56 6 6 5.89
Total monounsaturated fatty acids, % 1.6 2.10 1.24 2.10
Polyunsaturated fatty acids, % 1.42 1.15 2.19 0.87
cholesterol, ppm 200 500 500 500
Linoleic acid, % 1.22 1.57 2.16 1.60
Omega-3 fatty acid, % 0.19 0.19 0.03 0.14
choline chloride, ppm 2250 2299 0.00 1200
Methionine, % 0.67 0.43 0.13 0.4
Fiber, % 5.1 5.1 0.0 4.6
nitrogen-free extract, % 48.7 42.5 – 46.4
Starch, % 31.9 28.37 – 36.89
Sucrose, % 3.70 2.21 – 1.34
Total digestible nutrients, % 76 81 – 80.9
calories provided by:
Protein, % 28.5 27.5 14.4 24.5
Fat, % 13.5 25.6 21.3 25
carbohydrates, % 57.9 46.9 64.3 50.6
Abbreviations: 5A4C, diet adequate in methionine and choline levels; 5D4F, diet deficient in methionine and devoid of choline; 5D4E, diet deficient in choline but with 
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cholesterol was calculated by the Friedewald equation.18 
The atherogenic index was determined as (total cholesterol-
HDL cholesterol)/HDL cholesterol.19
collection of the liver
The whole liver was excised from each animal, immersed in 
chilled phosphate-buffered saline and blotted dry. A 4 mm 
section of the liver was placed into a histological cassette. 
The cassette containing the liver section of each animal was 
individually immersed in a 10% (v/v) buffered formalin 
phosphate solution for fixing and subsequent staining.
histology
Liver sections soaked in 10% buffered formalin phosphate 
solution were processed for normal histological section. 
The formalin-fixed, paraffin-embedded tissue samples were 
ultrasectioned (4–5 µm thickness), stained with hema-
toxylin and eosin and Oil red O, and examined under a light 
microscope.
Statistical analysis
Results were expressed as mean ± standard deviation. The 
significance of the difference between the means of test and 
control studies was established by repeated-measures analy-
sis of variance. An alpha level of 0.05 was set to determine 
statistical significance (P , 0.05).
Results
Following a two-week acclimatization to the basal control 
diet, the animals were sorted into control and diet groups 
based on basal serum total cholesterol concentrations to start 
the experimental period. During the four-week experimental 
acute feeding period, the animals were divided into four 
groups, including control animals that received a normal 
diet. Three different hypercholesterolemic-hyperlipidemic 
diets were tested during the study, ie, a diet with adequate 
methionine and choline levels (5A4C), a diet deficient in 
choline but with adequate levels of methionine (5D4E) and, 
lastly, a diet which was deficient in methionine and devoid 
of choline (5D4F).
Body weight and general health
The body weights of all animals were monitored at 10-day 
intervals and are presented in Figure 1. Animals in all treat-
ment groups showed an increase in body weight over the 
duration of study, which could be attributed to the normal 
growth phase and the hyperlipidemic diets. The animals fed 
on the 5D4E diet showed the highest increase in body weight 
(21.3%), with each hamster putting on 7.25 g per week. The 
5A4C diet induced a 16% increase in body weight over the 
four-week period, with each animal gaining an average of 
5.25 g per week. The normal diet leads to an 8.6% increase 
in body weight, corresponding to a weight gain of 2.75 g per 
animal per week. In contrast, hamsters fed on the 5D4F diet 
did not show any significant weight gain during the experi-
mental period. Diets deficient in methionine and choline have 
been proven to lead to weight loss in rodent models studied 
earlier.20 However, the hamsters fed on this choline-devoid 
diet showed marked differences in their physical appearance. 
These animals showed crusting of the upper lip, loss of fur 
texture with the hair appearing wet or greasy, and were gener-
ally very sluggish. The animals fed on the other diets were all 
very active and appeared to be in good health. Food intake 
was significantly lower in hamsters on diets which were either 
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Figure 1 Average animal weight on food intake and food efficiency ratio. A) normal diet, B) 5A4c, C) 5D4F, and D) 5D4e.
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deficient or devoid of choline (Figure 1) compared with the 
other two diets. Methionine-deficient and choline-deficient 
diets have been associated with lower food intakes in prior 
studies on rodents.21,22 The 5D4E diet showed the best food 
efficiency ratio among the diets evaluated.
Serum total cholesterol levels
Compared with the baseline control level, serum total choles-
terol levels were elevated in all groups of animals on the test 
diets (Figure 2A). As other short-term studies have shown, 
this elevation of serum total cholesterol concentration likely 
resulted from the dietary cholesterol ingested.23,24 Hamsters 
fed the 5D4E diet showed a dramatic increase (232%) in 
serum total cholesterol levels (P , 0.0001). The 5A4C diet 
led to a 25% increase in total cholesterol levels over the four-
week study (P = 0.084). Total cholesterol levels in hamsters 
on the 5D4F diet increased during the first two weeks, but 
reduced during the next two weeks, showing a 16% reduction 
in serum total cholesterol levels (P = 0.038).
Serum hDL and LDL cholesterol  
and triglycerides
HDL cholesterol decreased over the study period in all the 
experimental diet groups compared with the group on the 
normal diet (Figure 2B). The 5D4F diet showed the highest 
decrease in serum HDL cholesterol levels (P , 0.0001), 
followed by the 5D4E (P = 0.0006) and 5A4C (P = 0.0014) 
diets. In contrast, hamsters fed with the 5D4E diet showed 
a dramatic increase in LDL cholesterol levels (P , 0.0001) 
during the study, compared with those on a normal diet, the 
values for which remained stable (Figure 2C). The 5A4C diet 
had a similar effect on LDL cholesterol levels (P = 0.0049) 
although not to the same extent as did the 5D4E diet. Serum 
LDL cholesterol values for animals fed with the 5D4F diet 
showed a decreasing trend (P = 0.82). Hamsters fed with 
the 5D4E diet (P = 0.0007), 5D4F diet (P = 0.27), and the 
normal diet showed an increase in serum triglycerides, while 
the triglyceride values decreased for those with the 5A4C 
diet (P = 0.086, Figure 2D).
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Figure 2 changes with time in serum A) total cholesterol, B) hDL cholesterol, C) LDL cholesterol, and D) triglycerides of hamsters (n = 8 per group) fed with a normal 
diet, 5A4C, 5D4F, or 5D4E. Animals were sacrificed after having been fed the respective diets ad libitum for four weeks. Liver triglycerides and serum lipoproteins were 
determined biweekly. each point represents the mean ± standard deviation.
Notes: *P , 0.0001 for total cholesterol; *P = 0.0006 for hDL cholesterol; *P , 0.0001 for LDL cholesterol; and *P = 0.0007 for triglycerides.
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; 5A4C, diet adequate in methionine and choline; 5D4F, diet deficient in methionine and choline; 
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glucose and atherogenic index
Glucose levels were elevated in all animals to varying 
extents. These doubled in the hamsters fed on the 5D4E 
diet (P , 0.0001), while those on the 5A4C diet showed an 
increase of 85% compared with baseline values (P = 0.011). 
In comparison, serum glucose levels showed a 48% and 25% 
increase in hamsters fed with the 5D4F diet (P = 0.0046) and 
normal diets, respectively (Figure 3A). The atherogenic index, 
which is correlated with cardiovascular disease, increased 
over five-fold in animals on the 5D4E diet (P , 0.0001), 
and by 50% in animals on the 5A4C diet (P = 0.0008). It 
remained stable in animals on the normal and 5D4F diets 
(P = 0.0020, Figure 3B).
histopathology
Histopathological analysis of hamster liver samples through 
H&E and Oil red O staining show marked differences 
between the diets studied. Hematoxylin and eosin staining 
demonstrated elevated amounts of fat deposits in liver tissue 
from animals fed on the test diets (Figures 4B, 4C, and 4D) 
compared with the normal diet (Figure 4A).   Macrovesicular 
deposition of fat and hepatocellular ballooning was observed 
in hamsters fed on the 5D4F (Figure 4B) while microve-
sicular fat deposits and ballooning to a lesser extent were 
found in hamsters on diets of 5A4C (Figure 4C) and 5D4E 
(Figure 4D). Oil red O staining of the liver tissue samples 
substantiate these results (Figure 5). A very high amount 
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Figure 3 effect on A) atherogenic index and B) serum glucose on Bio F1B hamsters (n = 8 per group) on administering a normal diet, 5A4c, 5D4F, or 5D4e. each point 
represents the mean ± standard deviation.
Notes: *P , 0.0001 for serum glucose and atherogenic index.
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of fat   deposition was found in hamsters fed on diet 5D4F 
(Figure 5C), followed by 5D4E (Figure 5D). Histological 
analysis confirm the development of fatty liver in animal 
models fed with the three test diets, compared with those on 
a normal diet. However, there were no signs of fibrosis.
Discussion
Animal models offer a convenient medium to investigate 
and understand the pathophysiology of disease and facilitate 
development of means to prevent or treat the studied disease. 
Studies on such models greatly contribute towards enhancing 
knowledge in the field. Animal models that express clinical 
manifestations of metabolic syndrome, such as insulin resis-
tance, fatty liver, and dyslipidemia, will be of immense value 
in understanding metabolic syndrome. We have investigated 
induction of metabolic syndrome in male Bio F1B Golden 
Syrian hamsters through nutritional intervention. The use of 
only male hamsters was encouraged to avoid gender-related 
response due to female hormones on a fatty acid diet.25
Serological and histopathological changes in hamsters fed 
on hyperlipidemic diets varying in methionine and choline 
levels in comparison with a normal diet were evaluated dur-
ing this study. Our results suggest that BioF1B Golden Syrian 
hamsters are a potential model for diet-induced metabolic 
syndrome with associated non-alcoholic fatty liver disease.
Among the three test diets, the choline-deficient 5D4E 
diet provided optimal induction of metabolic syndrome, 
while the methionine-deficient/choline-devoid 5D4F lead 
to some undesirable effects on the normal well being of the 
animals. The hamsters displayed several manifestations of 
the human metabolic syndrome. The hyperlipidemic effects 
of the diets were visibly demonstrated in the increased 
body weight and lipid profile of serological samples from 
hamsters fed on the test diets. The animals showed hyper-
glycemia and an elevated atherogenic index, which are 
commonly   associated with metabolic syndrome. In addition, 
histopathological analysis revealed extensive diet-induced 
hepatocellular fat deposition and ballooning in the liver 
samples from the hamsters, while the control hamsters had 
normal liver   histology. However, the spectrum of conditions 
characterized by fatty change in the liver had not progressed 
to necrosis, fibrosis, or inflammation. In comparison with the 
normal diet, the hyperlipidemic diets were also associated 
with elevated serum total cholesterol levels, decreased HDL 
cholesterol, and hyperglycemia and hypertriglyceridemia, 
thereby confirming the induction of metabolic syndrome and 
nonalcoholic fatty liver in the hamsters.
It is evident that special diets are needed to develop and 
study an animal model of metabolic syndrome. However, no 
phenotype of any animal model is guaranteed, and cautious 
choosing of the species and strain as well as satisfactory 
control over environmental factors is important. In this paper, 
we have shown that BioF1B Golden Syrian hamsters can be 
used as a model that develops clinical and histopathological 
manifestations of the human metabolic syndrome through 
dietary intervention. It is known that the dietary factors 
may promote multiple phenotypes,26,27 for example, the use 
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Figure 4 hematoxylin and eosin staining of liver tissue from hamsters fed with 
hyperlipidemic  diets.  Magnification  400×.  A)  normal  diet,  B)  diet  adequate  in 
methionine and choline (5A4c), C) diet deficient in methionine and choline (5D4F), 
and D) diet adequate in methionine and deficient in choline (5D4E). Hepatocytes 
are filled with microvascular and macrovesicular fat deposits, leaving the nuclei in a 
central position, and the hepatocytes have assumed a very foamy appearance.
AB
CD
Figure 5 Oil red O staining of liver tissue from hamsters fed on hyperlipidemic 
diets. Magnification 400×. A) normal diet, B) diet adequate in methionine and 
choline (5A4c), C) diet deficient in methionine and choline (5D4F), and D) diet 
adequate in methionine and deficient in choline (5D4E). Hamster hepatocytes are 
filled with microvesicular and/or macrovesicular fat deposits; they are depicted as 
reddish-orange deposits, as shown with Oil red O staining.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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of high-fat diets induces obesity, insulin resistance, and 
hyperglycemia and the use of high-fructose diets promote 
insulin resistance, hypertriglyceridemia, and hypertension. 
However, we did not monitor for reversion of the phenotypic 
characteristics of the animal model by replacing their diet 
from hyperglycemic to normal diet. In addition, it should be 
noted that the hamster diet, although adequate for the pro-
posed work, does not represent an actual human diet that can 
potentially stimulate nonalcoholic fatty liver disease. Thus, 
this study opens up new approaches to investigate further the 
long-term effects of choline deprivation on the animal model. 
This concurrent advance of diseases is not unexpected, given 
the multifaceted interactions and relationships between these 
diseases. At present, diet-induced animal models of metabolic 
syndrome are still being developed, and there may not be one 
single model that will satisfy all metabolic disease research 
needs. Ongoing research using different species/strains along 
with existing and new purified ingredient diet formulations 
should lead to the development of more and more useful 
metabolic syndrome phenotypes.
Conclusion
In conclusion, we have developed a successful model of 
metabolic syndrome in BioF1B Golden Syrian hamsters. This 
metabolic syndrome model with hyperlipidemia and insulin 
resistance was established (along with nonalcoholic fatty 
liver) in hamsters fed a high-fat, high-cholesterol, inadequate 
methionine- and choline-containing diet. This model may be 
useful for the evaluation of preventive medicine, including 
food factors, for obesity-induced metabolic syndrome. The 
increasing prevalence of obesity, diabetes and insulin resis-
tance, and nonalcoholic fatty liver disease within Western 
society makes research in this field vital. In addition, using 
this model, it may be possible to elucidate the mechanisms 
involved in the development of metabolic syndrome, espe-
cially the association between lipid accumulation-induced 
dysfunction of hepatocytes and the induction of insulin 
resistance. It is only through better understanding of patho-
genic mechanisms that novel therapies targeting the cluster 
of diseases in metabolic syndrome may be discovered.
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